ASM Microbe 2021 will host thousands of poster presentations where scientists will obtain valuable feedback on their research and gain new perspectives from leading experts. Take advantage of the opportunity to get your latest research in front of experts and peers in the microbial sciences! 

Abstract submission and travel awards opens Nov. 16, 2020.  Stay tuned for more details.
 

Abstract Submission and Travel Award Requests Open
Nov. 16, 2020

Early Abstract Submission Closes
Dec. 3, 2020

Early Abstract Dispositions Sent
Dec. 18, 2020

Abstract Submission and Travel Award Requests Closes
Jan. 25, 2021, 5 p.m. EST
 

• Abstract Title: Please use a short and concise title that indicates the content of the abstract. (Please note: The title is not included in the total character count of 2200). 
• Abstract Body Text: Your abstract may have up to 2200 characters, which does not include title, authors, groups, and affiliations. Tables and graphics (maximum of 500 characters) are included in the character count. Spaces are not counted. Do NOT include abstract title, authors or keywords in abstract text. Abstract text may be submitted using either of the following methods: Copy/paste, direct entry keystrokes, or file upload. Your abstract may be written without the use of the following bolded headers (e.g., Background, Methods, Results, Conclusion). However, follow the abstract guidelines to ensure all required information about your study is provided in your abstract. 
• Author(s) Information: Author(s)'s name(s), institution(s), location(s), title(s). 
• CE Disclosures: Relative to this activity, instructors, planners, content reviewers and managers who affect the content of a CME/CE activity are required to disclose relevant financial relationships they have with commercial interests (i.e., any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients).

Technical Support
If you have any questions regarding use of the abstract submission site, please contact technical support at asm@support.ctimeetingtech.com.  


Have additional questions? View our FAQs.
FAQs

All Submitted Abstracts

• It is preferred that ASM Microbe 2021 be the first major presentation of the abstract.
• A presenter may be a presenter on more than one abstract.
• Programming decisions are considered final.
• Abstracts must be well written and easy to understand.
• Approval of all co-authors must be obtained before placing their names on an abstract.
• Submission of multiple overlapping abstracts is discouraged.

Clinical Tracks (AAR, CPHM, CIV, POM) 

• The reason for the study, or how the study came about, (e.g. hypothesis, discovery or central question) should be clearly stated.
• Methods must be included.
• Data must be objectively gathered, analyzed and reported.
• Data must support the stated conclusion(s).
• All presentations dealing with the isolation, purification, structure-activity relationships, mechanisms of action, in vivo/in vitro microbiology, PK/PD in animals and Pre-US IND or non-US early phase I studies must include meaningful data (e.g., producing organism, purification steps, physical-chemical characterization, structures, MICs, ED50s) to describe new compounds and their properties, and that chemical structures of lead compounds will be included as part of the poster presentation. Please note: Any posters or talks dealing with a specific small molecule antimicrobial agent must provide a chemical structure, or a literature reference to the structure, in order to be presented at the meeting. Abstracts describing biological data on an antimicrobial agent whose chemical structure has not been defined should be submitted to the HMB track.

• Scientific presentations at ASM Microbe 2021 will be expected to transparently report a study’s scientific rigor, including but, not limited to the following: 1) experimental design; 2) methodology; 3) data collection; 4) analysis and 5) interpretation and report of results. Other key components of scientific rigor included, if applicable, are sample size, randomization, blinding, and replication.

Basic Science Tracks (AES, EEB, HMB, MBP)

• The reason for the study or how the study came about, (e.g. hypothesis, discovery or central question) should be clearly stated.
• Data must be objectively gathered, analyzed and reported.
• Data must support the stated conclusion(s).
• Conclusion(s) should be made but, the study does not need to be fully complete (the standard to present at Microbe is not the same as to publish in a journal).
• Abstracts describing biological data on an antimicrobial agent whose chemical structure has not been defined should be submitted to the HMB track.
• Scientific presentations at ASM Microbe 2021 will be expected to transparently report a study’s scientific rigor, including, but not limited to the following: 1) experimental design and 2) interpretation and report of results. 

All ASM Microbe abstracts will be embargoed until June 3, 2021. Some abstracts will be embargoed to coincide with the times they are presented at the meeting. Embargo times and dates will be clearly marked on all press releases.

Additionally, press releases and other promotional activity by third parties must coincide with the date and time of the presentation.

When asking for outside comment on press releases or news stories before the embargo has lifted, journalists are requested to ensure that the embargo is respected. ASM reserves the right to ban any journalist from the meeting who breaks the embargo or breaches the media policy in any other way.

If your research has already been published, please contact the ASM communications office to discuss how to handle promoting your abstract at communications@asmusa.org.
 

Plagiarism will not be tolerated in submitted abstracts. All submitted abstracts identified with plagiarism will be sent to the Program Committee for review and handling. 

The NIH ORI publication AVOIDING PLAGIARISM, SELF-PLAGIARISM, AND OTHER QUESTIONABLE